SMG5
gene geneOn this page
Also known as KIAA1089LPTS-RP1LPTSRP1RP11-54H19.7SMG-5EST1B
Summary
SMG5 (SMG5 nonsense mediated mRNA decay factor, HGNC:24644) is a protein-coding gene on chromosome 1q22, encoding Nonsense-mediated mRNA decay factor SMG5 (Q9UPR3). Plays a role in nonsense-mediated mRNA decay. It is a common-essential gene (DepMap: required in 98.4% of cancer cell lines).
SMG5 is involved in nonsense-mediated mRNA decay (Ohnishi et al., 2003 [PubMed 14636577]).
Source: NCBI Gene 23381 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 237 total
- Cancer dependency (DepMap): dependent in 98.4% of screened cell lines (common-essential)
- MANE Select transcript:
NM_015327
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24644 |
| Approved symbol | SMG5 |
| Name | SMG5 nonsense mediated mRNA decay factor |
| Location | 1q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5, EST1B |
| Ensembl gene | ENSG00000198952 |
| Ensembl biotype | protein_coding |
| OMIM | 610962 |
| Entrez | 23381 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 22 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000361813, ENST00000468993, ENST00000473643, ENST00000476954, ENST00000489907, ENST00000858600, ENST00000858601, ENST00000858602, ENST00000858603, ENST00000858604, ENST00000858605, ENST00000858606, ENST00000858607, ENST00000858608, ENST00000858609, ENST00000858610, ENST00000925518, ENST00000925519, ENST00000925520, ENST00000925521, ENST00000956492, ENST00000956493, ENST00000956494, ENST00000956495, ENST00000956496, ENST00000956497
RefSeq mRNA: 5 — MANE Select: NM_015327
NM_001323614, NM_001323615, NM_001323616, NM_001323617, NM_015327
CCDS: CCDS1137
Canonical transcript exons
ENST00000361813 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001054400 | 156261333 | 156261408 |
| ENSE00001054402 | 156267470 | 156267678 |
| ENSE00001054403 | 156251403 | 156251477 |
| ENSE00001054404 | 156252414 | 156252504 |
| ENSE00001054405 | 156268290 | 156268415 |
| ENSE00001054406 | 156263395 | 156263570 |
| ENSE00001054407 | 156273361 | 156273450 |
| ENSE00001054409 | 156268115 | 156268183 |
| ENSE00001054410 | 156272320 | 156272398 |
| ENSE00001054413 | 156266541 | 156266678 |
| ENSE00001054415 | 156252919 | 156253078 |
| ENSE00001054416 | 156260451 | 156260626 |
| ENSE00001054417 | 156265781 | 156266380 |
| ENSE00001054418 | 156250858 | 156250996 |
| ENSE00001075011 | 156277925 | 156278048 |
| ENSE00001075015 | 156277085 | 156277241 |
| ENSE00001075017 | 156274597 | 156274686 |
| ENSE00001196892 | 156278936 | 156279034 |
| ENSE00001446733 | 156249224 | 156250670 |
| ENSE00001446734 | 156282607 | 156282825 |
| ENSE00003436026 | 156259005 | 156259163 |
| ENSE00003442982 | 156253449 | 156253508 |
Expression profiles
Bgee: expression breadth ubiquitous, 286 present calls, max score 96.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 54.5890 / max 347.1460, expressed in 1825 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15097 | 54.2128 | 1825 |
| 15099 | 3.5002 | 1173 |
| 15098 | 0.2801 | 137 |
| 15096 | 0.0960 | 28 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 96.19 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.11 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.25 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.20 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.91 | gold quality |
| granulocyte | CL:0000094 | 94.90 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.89 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.82 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.77 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.69 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.68 | gold quality |
| skin of leg | UBERON:0001511 | 94.62 | gold quality |
| muscle of leg | UBERON:0001383 | 94.50 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.48 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.45 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.44 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.40 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.35 | gold quality |
| pituitary gland | UBERON:0000007 | 94.26 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.20 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.14 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.14 | gold quality |
| right lobe of liver | UBERON:0001114 | 94.08 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.05 | gold quality |
| ventricular zone | UBERON:0003053 | 93.98 | gold quality |
| lower esophagus | UBERON:0013473 | 93.96 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 93.95 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 93.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.88 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
80 targeting SMG5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-196A-3P | 99.19 | 67.34 | 1204 |
| HSA-MIR-7109-5P | 99.18 | 66.13 | 1057 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 98.4% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 9)
- Data show that phosphorylated hUPF1, the human ortholog of UPF1/SMG-2, forms a complex with human orthologs of the Caenorhabditis elegans proteins SMG-5 and SMG-7. (PMID:14636577)
- HDAC8 regulation of hEST1B protein stability modulates total telomerase enzymatic activity (PMID:16809764)
- The study demonstrates that SMG5-SMG7 and SMG6 exhibit different and non-overlapping modes of UPF1 recognition, thus pointing at distinguished roles in integrating the complex nonsense-mediated mRNA decay interaction network. (PMID:25013172)
- Depletion of nonsense-mediated mRNA decay pathway components Upf1, Smg5, and Smg7 led to increased levels of viral proteins and and virus release. (PMID:25211080)
- This study highlights that miR-433 represses nonsense mediated mRNA decay. The miR-433 targets 3’-UTR of SMG5 and represses the expression of SMG5, whereas nonsense-mediated mRNA decay activity is decreased when SMG5 is decreased. (PMID:27473591)
- The authors found no evidence for the existence of a physical or functional interaction between SMG5 and PNRC2. (PMID:29348139)
- SMG5-SMG7 authorize nonsense-mediated mRNA decay by enabling SMG6 endonucleolytic activity. (PMID:34172724)
- Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers. (PMID:37699361)
- Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinoma. (PMID:37936239)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | smg5 | ENSDARG00000041481 |
| mus_musculus | Smg5 | ENSMUSG00000001415 |
| rattus_norvegicus | Smg5 | ENSRNOG00000019590 |
| drosophila_melanogaster | Smg5 | FBGN0019890 |
Paralogs (1): SMG7 (ENSG00000116698)
Protein
Protein identifiers
Nonsense-mediated mRNA decay factor SMG5 — Q9UPR3 (reviewed: Q9UPR3)
Alternative names: EST1-like protein B, LPTS-RP1, LPTS-interacting protein, SMG-5 homolog
All UniProt accessions (1): Q9UPR3
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in nonsense-mediated mRNA decay. Does not have RNase activity by itself. Promotes dephosphorylation of UPF1. Together with SMG7 is thought to provide a link to the mRNA degradation machinery involving exonucleolytic pathways, and to serve as an adapter for UPF1 to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation. Necessary for TERT activity.
Subunit / interactions. Interacts with TERT, PPP2CA and SMG1. Part of a complex that contains SMG1, SMG5, SMG7, PPP2CA, a short isoform of UPF3A (isoform UPF3AS, but not isoform UPF3AL) and phosphorylated UPF1. Not detected in complexes that contain unphosphorylated UPF1.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Ubiquitous.
RefSeq proteins (5): NP_001310543, NP_001310544, NP_001310545, NP_001310546, NP_056142* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002716 | PIN_dom | Domain |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR018834 | DNA/RNA-bd_Est1-type | Domain |
| IPR019458 | Est1-like_N | Domain |
| IPR045153 | Est1/Ebs1-like | Family |
Pfam: PF10373, PF10374, PF13638
UniProt features (30 total): helix 7, strand 5, sequence conflict 4, modified residue 3, compositionally biased region 3, region of interest 2, initiator methionine 1, chain 1, sequence variant 1, mutagenesis site 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2HWY | X-RAY DIFFRACTION | 2.75 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UPR3-F1 | 73.72 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 2, 423, 2
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 860 | abolishes stimulation of rent1 dephosphorylation. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
| R-HSA-8953854 | Metabolism of RNA |
| R-HSA-927802 | Nonsense-Mediated Decay (NMD) |
MSigDB gene sets: 199 (showing top):
GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS, PID_HDAC_CLASSI_PATHWAY, RNGTGGGC_UNKNOWN, GOBP_CHROMOSOME_ORGANIZATION, PID_TELOMERASE_PATHWAY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING, GOBP_TELOMERE_ORGANIZATION, CAGCTG_AP4_Q5, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, PATIL_LIVER_CANCER, GOBP_NUCLEAR_TRANSPORT, GOBP_REGULATION_OF_TELOMERE_MAINTENANCE, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT
GO Biological Process (5): nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184), mRNA export from nucleus (GO:0006406), regulation of telomere maintenance (GO:0032204), regulation of telomere maintenance via telomerase (GO:0032210), regulation of dephosphorylation (GO:0035303)
GO Molecular Function (6): ubiquitin protein ligase binding (GO:0031625), telomeric repeat DNA binding (GO:0042162), histone deacetylase binding (GO:0042826), protein phosphatase 2A binding (GO:0051721), telomerase RNA binding (GO:0070034), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), telomerase holoenzyme complex (GO:0005697), cytoplasm (GO:0005737), cytosol (GO:0005829), cytoplasmic ribonucleoprotein granule (GO:0036464)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Nonsense-Mediated Decay (NMD) | 1 |
| Metabolism of RNA | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| nuclear-transcribed mRNA catabolic process | 1 |
| RNA export from nucleus | 1 |
| gene expression | 1 |
| mRNA transport | 1 |
| telomere maintenance | 1 |
| regulation of chromosome organization | 1 |
| regulation of DNA metabolic process | 1 |
| telomere maintenance via telomerase | 1 |
| regulation of telomere maintenance via telomere lengthening | 1 |
| regulation of DNA biosynthetic process | 1 |
| dephosphorylation | 1 |
| regulation of metabolic process | 1 |
| ubiquitin-like protein ligase binding | 1 |
| sequence-specific DNA binding | 1 |
| enzyme binding | 1 |
| protein phosphatase binding | 1 |
| RNA binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear protein-containing complex | 1 |
| catalytic complex | 1 |
| ribonucleoprotein complex | 1 |
| intracellular anatomical structure | 1 |
| ribonucleoprotein granule | 1 |
Protein interactions and networks
STRING
1814 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMG5 | UPF1 | Q92900 | 999 |
| SMG5 | SMG7 | Q92540 | 991 |
| SMG5 | UPF2 | Q9HAU5 | 978 |
| SMG5 | SMG6 | Q86US8 | 970 |
| SMG5 | SMG1 | Q96Q15 | 962 |
| SMG5 | UPF3A | Q9H1J1 | 960 |
| SMG5 | PNRC2 | Q9NPJ4 | 951 |
| SMG5 | UPF3B | Q9BZI7 | 934 |
| SMG5 | SMG8 | Q8ND04 | 903 |
| SMG5 | SMG9 | Q9H0W8 | 847 |
| SMG5 | SULT1E1 | P49888 | 832 |
| SMG5 | HDAC8 | Q9BY41 | 819 |
| SMG5 | STAU1 | O95793 | 789 |
| SMG5 | XRN1 | Q8IZH2 | 775 |
| SMG5 | DCP1A | Q9NPI6 | 744 |
IntAct
35 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TP53 | CSNK2A2 | psi-mi:“MI:0914”(association) | 0.730 |
| UPF3B | RNPS1 | psi-mi:“MI:0914”(association) | 0.640 |
| SMG7 | UPF1 | psi-mi:“MI:0914”(association) | 0.620 |
| UPF1 | SMG7 | psi-mi:“MI:0914”(association) | 0.620 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| SMG5 | SMG7 | psi-mi:“MI:0914”(association) | 0.500 |
| UPF1 | SMG5 | psi-mi:“MI:0915”(physical association) | 0.500 |
| SMG5 | SMG7 | psi-mi:“MI:0915”(physical association) | 0.500 |
| DDX21 | MED19 | psi-mi:“MI:2364”(proximity) | 0.480 |
| SMG5 | H2BC13 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMG5 | H2BC21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMG5 | H2BC5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SMG5 | TERT | psi-mi:“MI:0915”(physical association) | 0.400 |
| TP53 | MDM2 | psi-mi:“MI:0914”(association) | 0.350 |
| C6orf141 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| UPF1 | PABPC1 | psi-mi:“MI:0914”(association) | 0.350 |
| UPF3A | RNPS1 | psi-mi:“MI:0914”(association) | 0.350 |
| SYT2 | ARHGAP10 | psi-mi:“MI:0914”(association) | 0.350 |
| CFAP184 | TARS3 | psi-mi:“MI:0914”(association) | 0.350 |
| DUSP16 | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| TP53 | PPM1G | psi-mi:“MI:0914”(association) | 0.350 |
| CEP152 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PCM1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CPEB1 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| RB1CC1 | TRAPPC13 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (92): SMG5 (Affinity Capture-RNA), SMG5 (Affinity Capture-RNA), SMG5 (Affinity Capture-Western), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Affinity Capture-MS), SMG5 (Reconstituted Complex), SMG5 (Affinity Capture-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS), SMG5 (Proximity Label-MS)
ESM2 similar proteins: A2A690, A2AWP8, A2RRU4, F1LQY6, F1LTE0, F1LXF1, O88842, O94827, O95267, P11274, P49797, Q0P5I0, Q14161, Q14CM0, Q29RM4, Q3B7L5, Q3UHE1, Q5JSP0, Q5R5M3, Q5R5T1, Q5T6S3, Q5XIS9, Q66H91, Q66T02, Q68FF6, Q6PAJ1, Q6RFZ7, Q6ZN54, Q6ZPY2, Q6ZR37, Q76JQ2, Q7Z6G3, Q80YA9, Q8BZ03, Q8R1S4, Q8TBP0, Q8TCU6, Q8WXI2, Q91ZP9, Q96JH8
Diamond homologs: A9QM73, F1R7R1, Q6ZPY2, Q9UPR3
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| STUB1 | “down-regulates quantity by destabilization” | SMG5 | polyubiquitination |
| HDAC8 | “up-regulates quantity by stabilization” | SMG5 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 39 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 6 | 22.5× | 5e-05 |
| Oxidative Stress Induced Senescence | 5 | 17.4× | 1e-03 |
| Ub-specific processing proteases | 5 | 10.2× | 3e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5 | 66.9× | 4e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
237 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 183 |
| Likely benign | 10 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3227 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:156250853:CCCA:C | donor_loss | 1.0000 |
| 1:156250854:CCAC:C | donor_loss | 1.0000 |
| 1:156250855:CA:C | donor_loss | 1.0000 |
| 1:156250856:A:AG | donor_loss | 1.0000 |
| 1:156250857:C:A | donor_loss | 1.0000 |
| 1:156252409:CTCA:C | donor_loss | 1.0000 |
| 1:156252412:A:AC | donor_gain | 1.0000 |
| 1:156252412:A:C | donor_loss | 1.0000 |
| 1:156252413:C:CA | donor_loss | 1.0000 |
| 1:156252413:C:CC | donor_gain | 1.0000 |
| 1:156252500:GATCA:G | acceptor_gain | 1.0000 |
| 1:156252501:ATCA:A | acceptor_gain | 1.0000 |
| 1:156252502:TCA:T | acceptor_gain | 1.0000 |
| 1:156252503:CA:C | acceptor_gain | 1.0000 |
| 1:156252503:CAC:C | acceptor_gain | 1.0000 |
| 1:156252505:C:CC | acceptor_gain | 1.0000 |
| 1:156252508:G:GC | acceptor_gain | 1.0000 |
| 1:156252513:C:CT | acceptor_gain | 1.0000 |
| 1:156252514:A:T | acceptor_gain | 1.0000 |
| 1:156252517:G:C | acceptor_gain | 1.0000 |
| 1:156252517:G:GC | acceptor_gain | 1.0000 |
| 1:156252913:ACTT:A | donor_gain | 1.0000 |
| 1:156252914:CTTA:C | donor_loss | 1.0000 |
| 1:156252915:TTA:T | donor_loss | 1.0000 |
| 1:156252915:TTAC:T | donor_gain | 1.0000 |
| 1:156252916:TACC:T | donor_gain | 1.0000 |
| 1:156252917:ACCT:A | donor_gain | 1.0000 |
| 1:156252918:C:CA | donor_loss | 1.0000 |
| 1:156252918:CCTGT:C | donor_gain | 1.0000 |
| 1:156253444:CCTA:C | donor_loss | 1.0000 |
AlphaMissense
6651 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:156252441:A:G | L909P | 1.000 |
| 1:156252479:C:A | K896N | 1.000 |
| 1:156252479:C:G | K896N | 1.000 |
| 1:156252492:A:G | L892P | 1.000 |
| 1:156253008:A:T | V858D | 1.000 |
| 1:156253011:A:G | L857P | 1.000 |
| 1:156253015:A:C | Y856D | 1.000 |
| 1:156253062:A:G | L840P | 1.000 |
| 1:156253062:A:T | L840Q | 1.000 |
| 1:156253077:A:G | L835P | 1.000 |
| 1:156253453:A:G | L833P | 1.000 |
| 1:156253453:A:T | L833H | 1.000 |
| 1:156253459:A:G | L831P | 1.000 |
| 1:156253465:G:T | A829D | 1.000 |
| 1:156253467:C:A | M828I | 1.000 |
| 1:156253467:C:G | M828I | 1.000 |
| 1:156253467:C:T | M828I | 1.000 |
| 1:156253468:A:G | M828T | 1.000 |
| 1:156253476:C:A | M825I | 1.000 |
| 1:156253476:C:G | M825I | 1.000 |
| 1:156253476:C:T | M825I | 1.000 |
| 1:156253477:A:G | M825T | 1.000 |
| 1:156253480:A:G | L824P | 1.000 |
| 1:156268394:A:C | F245L | 1.000 |
| 1:156268394:A:T | F245L | 1.000 |
| 1:156268396:A:G | F245L | 1.000 |
| 1:156272377:C:T | G219D | 1.000 |
| 1:156272378:C:G | G219R | 1.000 |
| 1:156273447:C:G | R183P | 1.000 |
| 1:156274602:T:A | D180V | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000026223 (1:156261113 C>T), RS1000164096 (1:156255040 G>A), RS1000195361 (1:156254219 C>G,T), RS1000242419 (1:156291240 A>G), RS1000247671 (1:156254486 C>A,G,T), RS1000274171 (1:156261267 G>A,C,T), RS1000394508 (1:156267170 T>C), RS1000528571 (1:156285065 G>C), RS1000549210 (1:156278538 T>A), RS1000665367 (1:156291779 C>T), RS1000718076 (1:156271614 C>A,T), RS1000919072 (1:156271366 T>C), RS1001065838 (1:156271390 A>G), RS1001137568 (1:156253306 G>A,C), RS1001150904 (1:156259501 C>T)
Disease associations
OMIM: gene MIM:610962 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000582_7 | Mean corpuscular hemoglobin concentration | 3.000000e-09 |
| GCST005145_1 | Glycated hemoglobin levels | 3.000000e-08 |
| GCST005992_1 | Mean corpuscular hemoglobin concentration | 1.000000e-16 |
| GCST006001_7 | Hemoglobin A1c levels | 1.000000e-18 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0004541 | HbA1c measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, increases abundance, decreases methylation, increases expression, affects cotreatment | 3 |
| sodium arsenite | increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| ginger extract | affects cotreatment, affects expression, increases abundance | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Oils, Volatile | increases abundance, affects cotreatment, affects expression | 1 |
| Selenium | affects cotreatment, decreases expression, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vitamin E | affects cotreatment, decreases expression, increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | increases expression, affects cotreatment | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.